FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner

Exp Cell Res. 2021 Apr 15;401(2):112524. doi: 10.1016/j.yexcr.2021.112524. Epub 2021 Feb 27.

Abstract

N6-Methyladenosine (m6A) modification is the most abundant chemical modification in mRNA, and it participates in various biological processes, such as cell differentiation and proliferation. However, little is known about the function of m6A demethylase fat mass and obesity-associated (FTO) in myoblast proliferation. Here, we demonstrated that knockdown of FTO can significantly inhibit myoblast proliferation and promote apoptosis. RNA sequencing analysis revealed that a lot of downregulated genes in FTO knockdown cells are associated with cell cycle and apoptosis. Furthermore, silencing FTO drastically decreased cyclin D1 (CCND1) expression through YTHDF2-mediated mRNA degradation, thereby delaying the progression of G1 phase, and leading to impaired myoblast proliferation. These findings unraveled that FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner, which highlights the critical roles of m6A modification in myoblast proliferation.

Keywords: Cell cycle; Cell proliferation; FTO; Myoblast; m(6)A modification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives
  • Adenosine / genetics
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO / genetics*
  • Apoptosis / genetics
  • Cell Cycle / genetics
  • Cell Differentiation / genetics
  • Cell Proliferation / genetics
  • Cyclin D1 / genetics*
  • G1 Phase / genetics
  • Humans
  • Myoblasts / metabolism
  • RNA Stability / genetics*
  • RNA-Binding Proteins / genetics*

Substances

  • CCND1 protein, human
  • RNA-Binding Proteins
  • YTHDF2 protein, human
  • Cyclin D1
  • N-methyladenosine
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • FTO protein, human
  • Adenosine